JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 51
  • -3-5.56%
20min DelayMarket Closed Nov 29 15:30 JST
4.35BMarket Cap-2800P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BrightPath Biotherapeutics H1 FY2025 Earnings Date

Currency：JPYNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
56.00K
--
+27.27%
EPS
--
-7.11
--
+19.30%
Analyst Rating
No Data

BrightPath Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

No Data

BrightPath Biotherapeutics Earnings Reports

  • BrightPath Biotherapeutics: Confirmation letter

    Nov 8 01:35 ET

  • BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

    Nov 8 01:34 ET

  • BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

    Nov 8 01:30 ET

  • BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).

    Aug 9 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data